Following a decade of successfully shaping market leaders across the rapidly evolving animal health market, Fidelio Capital AB (Fidelio) today announced the formation of Vimian – a global and diversified group of innovation-driven companies operating in four fast-growing animal health verticals. Headquartered in Stockholm, Sweden, Vimian and its family of companies serve more than 15,000 customers in +70 countries, employ over 400 people and have a combined turnover of approximately EUR 140 million.

Vimian and its family of companies cover four essential areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. All of these companies share a passion for making a positive impact through improving animal health, by delivering solutions, products and services to animals and veterinary professionals around the world.

“By establishing Vimian, we are creating a global platform with a clear ambition to lead the ongoing transformation of the animal health market. With Vimian, we are bringing together some of the most innovative, high-quality and entrepreneurial businesses under one umbrella, to create a uniquely diversified proposition of products and services across four high-growth animal health verticals”, says Gabriel Fitzgerald, Founder and CEO of Fidelio.

The first building block of Vimian was laid in 2015, when Fidelio invested in what was to become Nextmune, Vimian’s Specialty Pharma division. Since then, Fidelio has continued to partner with entrepreneurs, management teams and owners of market leading businesses within Diagnostics (Indical Bioscience), Veterinary Services (VetFamily) and MedTech (Movora). To date, 20 companies have joined the Vimian platform on its ongoing journey towards improving animal health for better lives.

“With Vimian, we combine the strengths and capabilities of a global group with the intimacy, speed and creativity of an owner-led business. By sharing knowledge, insights and resources across our family of businesses, we create an unmatched opportunity to accelerate innovation, talent acquisition and growth. Together, we are able to reach over 15,000 veterinary clinics and 1,500 labs globally, with exceptional science and technology throughout our four areas. We all share a passion for making a positive impact through improving animal health, and I look forward to an exciting journey ahead with the entire Vimian team”, says Dr. Fredrik Ullman, CEO of Vimian (former CEO of Indical Bioscience).

For further information, please contact:
Gabriel Fitzgerald, Founder and CEO of Fidelio
Email: gabriel.fitzgerald@fideliocapital.se / Mobile: +46 70 635 29 29
Fredrik Ullman, CEO of Vimian
Email: fredrik.ullman@vimian.com / Mobile: +41 79 580 80 60

About Vimian

Vimian is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to animals and veterinary professionals around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies serve over 15,000 customers in +70 countries, employ more than 400 people and have a combined turnover of approximately EUR 140 million. For more information, please visit: www.vimian.com.

About Fidelio

Fidelio is an independent Swedish investment company, founded by Gabriel Fitzgerald in 2010, with the determination to add a more flexible and entrepreneurial approach to the professional and active ownership model found within traditional Private Equity. We partner with entrepreneurs, management teams and fellow co-owners to help build outstanding businesses, without any pre-determined investment horizon. In addition to the team at Fidelio, our capital is provided by a select group of successful Nordic industrialists, entrepreneurs and families who allow us to take a visionary, creative and entrepreneurial approach to long-term value creation. For more information, please visit: www.fideliocapital.com.

Attachments

Fidelio forms Vimian – a global powerhouse within animal health

© Modular Finance, source Nordic Press Releases